Abstract
Age- related neurodegenerative diseases, especially Alzheimers disease (AD), are an important health problem globally. AD is clinically characterized by loss of memory, reasoning and speech. The frequency of the disease reaches to 20-40% in the population over the age of 85. Autopsy findings have indicated the presence of senile plaques and neurofibrillary tangles in the brains of patients with AD. These two lesions can be seen in small numbers during normal aging of the brain but occur in large amounts during AD. Although the initiating causes leading to AD are unknown, oxidative damage appears to play an important role in the slowly progressive neuronal death that is characteristic of AD. Indeed, in addition to the presence of senile plaques and neurofibrillary tangles, postmortem analysis of AD brain has also identified markers of oxidative stress including protein nitrotyrosine, carbonyls in proteins, lipid oxidation products and oxidized DNA bases. This review discusses the role of reactive oxygen and nitrogen species in the pathogenesis of AD and examines the relevance of antioxidant therapy in altering and / or inhibiting neurodegeneration associated with the disease.
Keywords: alzheimers disease, oxidative stress, reactive oxygen species, antioxidant
Current Alzheimer Research
Title: Reactive Oxygen and Nitrogen Species in Alzheimers Disease
Volume: 1 Issue: 2
Author(s): Mutay Aslan and Tomris Ozben
Affiliation:
Keywords: alzheimers disease, oxidative stress, reactive oxygen species, antioxidant
Abstract: Age- related neurodegenerative diseases, especially Alzheimers disease (AD), are an important health problem globally. AD is clinically characterized by loss of memory, reasoning and speech. The frequency of the disease reaches to 20-40% in the population over the age of 85. Autopsy findings have indicated the presence of senile plaques and neurofibrillary tangles in the brains of patients with AD. These two lesions can be seen in small numbers during normal aging of the brain but occur in large amounts during AD. Although the initiating causes leading to AD are unknown, oxidative damage appears to play an important role in the slowly progressive neuronal death that is characteristic of AD. Indeed, in addition to the presence of senile plaques and neurofibrillary tangles, postmortem analysis of AD brain has also identified markers of oxidative stress including protein nitrotyrosine, carbonyls in proteins, lipid oxidation products and oxidized DNA bases. This review discusses the role of reactive oxygen and nitrogen species in the pathogenesis of AD and examines the relevance of antioxidant therapy in altering and / or inhibiting neurodegeneration associated with the disease.
Export Options
About this article
Cite this article as:
Aslan Mutay and Ozben Tomris, Reactive Oxygen and Nitrogen Species in Alzheimers Disease, Current Alzheimer Research 2004; 1 (2) . https://dx.doi.org/10.2174/1567205043332162
DOI https://dx.doi.org/10.2174/1567205043332162 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats
Current Pharmaceutical Biotechnology Affective Temperaments and Mood Disorders: A Review of Current Knowledge
Current Psychiatry Reviews Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the Treatment of Parathyroid Tumors
Current Cancer Drug Targets Mitochondrial Dysfunctions in Bipolar Disorder: Effect of the Disease and Pharmacotherapy
CNS & Neurological Disorders - Drug Targets Opioids and Mechanical Ventilation
Current Drug Targets Biomarkers in Migraine Headache: Prognostic and Therapeutic Implications
Current Medicinal Chemistry The Pathogenic Mechanisms of Prion Diseases
CNS & Neurological Disorders - Drug Targets Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Running Exercise Reduces Myelinated Fiber Loss in the Dentate Gyrus of the Hippocampus in APP/PS1 Transgenic Mice
Current Alzheimer Research The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants
Current Neuropharmacology Amyloid β-Peptide: The Inside Story
Current Alzheimer Research The Role of Cannabinoid Receptors in Renal Diseases
Current Medicinal Chemistry Drug Repositioning for Treatment of Movement Disorders: From Serendipity to Rational Discovery Strategies
Current Topics in Medicinal Chemistry The Effects of Acute Tryptophan Depletion on Brain Activation During Cognition and Emotional Processing in Healthy Volunteers
Current Pharmaceutical Design Compared Chemical Activity and Effects on Cell Viability of Various Antioxidant Compounds
Current Analytical Chemistry Antidepressants and Sleep: Neurophysiology and Clinical Correlates
Current Psychiatry Reviews Unusual DNA Conformations: Implications for Telomeres
Current Medicinal Chemistry - Anti-Cancer Agents Commentary: (Research Highlights Inflammation, Demyelination and Neurodegeneration: Risky Buddies in Multiple Sclerosis)
CNS & Neurological Disorders - Drug Targets Janus Molecule I: Dichotomous Effects of COMT in Neuropathic vs Nociceptive Pain Modalities
CNS & Neurological Disorders - Drug Targets